There are currently 1262 clinical trials in Seattle, Washington looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Washington, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center and University of Washington Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
NCT05211856
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, Seattle, Washington
Conditions: Chronic Lymphocytic Leukemia
Register for Updates
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
NCT04598698
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Seattle Reproductive Medicine, Seattle, Washington
Conditions: Endometriosis
Register for Updates
Safety and Durability of Sirolimus for Treatment of LAM
NCT02432560
Recruiting
The MIDAS study aims to follow LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR inhibitors (sirolimus or everolimus) as part of their clinical care. Adult female TSC patients may also enroll, with or without lung cysts.
Gender:
Female
Ages:
18 years and above
Trial Updated:
01/11/2022
Locations: Swedish Medical Center, Seattle, Washington
Conditions: Lymphangioleiomyomatosis
Register for Updates
Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
NCT05186298
Recruiting
The purpose of this study is to evaluate the AcrySof PanOptix Intraocular Lens (IOL) for binocular distance corrected near visual acuity (DCNVA) compared to TECNIS Synergy IOL. Presbyopia correcting diffractive intraocular implants (extended depth of focus, multifocal, and trifocal) provide cataract and refractive surgeons with an effective treatment means for allowing patients to experience increased spectacle independence post-cataract surgery.
Gender:
All
Ages:
22 years and above
Trial Updated:
01/10/2022
Locations: Northwest Eye Surgeons, Seattle, Washington
Conditions: Cataract
Register for Updates
Flicker App for Minimal Hepatic Encephalopathy
NCT04415294
Recruiting
There is a great unmet clinical need for improved screening for MHE in patients with cirrhosis. We will demonstrate that the Flicker-App can be used in clinic as well as at home by patients with cirrhosis to measure CFF, a proven screening test for MHE. We will optimize the protocol, software, and hardware of the Flicker-App to create a product appropriate for production and distribution to patients
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
01/07/2022
Locations: University of Washington Medical Center, Seattle, Washington
Conditions: Hepatic Encephalopathy
Register for Updates
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
NCT04380870
Recruiting
The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
Gender:
All
Ages:
Between 18 years and 114 years
Trial Updated:
09/27/2021
Locations: Seattle Intstitute of East Asian Medicine, Seattle, Washington
Conditions: Coronavirus Infection
Register for Updates
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
NCT02543866
Recruiting
This protocol will evaluate fecal microbiota transplantation (FMT) as a strategy to eradicate intestinal colonization of extended-spectrum resistant (ESC-R) Enterobacteriaceae in pediatric patients. FMT will be performed on subjects with a history of at least one infection due to ESC-R Enterobacteriaceae. This protocol aims to determine the feasibility, safety, tolerability, and potential efficacy of FMT in pediatric patients with a history of ESC-R Enterobacteriaceae.
Gender:
All
Ages:
Between 7 years and 21 years
Trial Updated:
09/22/2021
Locations: Seattle Children's Hospital, Seattle, Washington
Conditions: Infection Resistant to Drugs
Register for Updates
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
NCT01874197
Recruiting
An investigator-initiated, prospective, consecutively enrolling, non-randomized single institution clinical evaluation of the safety and effectiveness of branched and fenestrated-branched endovascular stent grafts to preserve branch vessels when used in the treatment of patients with thoraco-abdominal aortic aneurysms. The study evaluates non-FDA-approved off the shelf and custom made branched and fenestrated-branched stent grafts manufactured by Cook Medical. The primary objectives of this stu... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/10/2021
Locations: University of Washington/Harborview Medical Center, Seattle, Washington
Conditions: Thoracoabdominal Aortic Aneurysm, Without Rupture
Register for Updates
A Crowd Sourcing Platform for Patients With Cancer
NCT03530826
Recruiting
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/19/2021
Locations: All4Cure, Seattle, Washington
Conditions: Cancer
Register for Updates
Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
NCT02927210
Recruiting
This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
Gender:
Male
Ages:
Between 18 years and 50 years
Trial Updated:
07/07/2021
Locations: University of Washington Medical Center & Health Sciences, Seattle, Washington
Conditions: Healthy Men, Male Contraception
Register for Updates
VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans
NCT04805931
Recruiting
This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different targeted outreach interventions aimed at increasing Covid-19 vaccine uptake. Veterans who are eligible for COVID-19 vaccine receipt by priority status (based on institutional guidelines) will be identified. Veterans must be enrolled into Veterans Health Administration (VHA) care and meet age or illness institutional priority guidelines to be eligible. Veterans eligible for enrollment into the... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/25/2021
Locations: VA Puget Sound Health Care System, Seattle, Washington
Conditions: Covid19, Vaccine Refusal
Register for Updates
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
NCT04948151
Recruiting
This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.
Gender:
Female
Ages:
21 years and above
Trial Updated:
06/24/2021
Locations: Seattle Women's Health Research - Gynecology, Seattle, Washington
Conditions: Female Sexual Arousal Disorder
Register for Updates